Andrew Saik

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Chesterbrook, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jared Freedberg, as attorney-in-fact for Andrew Saik
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Andrew Saik

Form 4 holding Chief Financial Officer

ARVINAS, INC.

Security class
Common Stock
Shares / value
187,432
Estimated value
$1,529,257
Report date
24 Jun 2026
Price
$8.16
Ownership
Direct
Form 4 holding Chief Financial Officer

ARVINAS, INC.

Security class
Stock Option (right to buy)
Shares / value
67,000
Estimated value
$1,199,360
Report date
26 Feb 2026
Price
$16.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

VYNE Therapeutics Inc.

Security class
Common Stock
Shares / value
116,468
Estimated value
$265,547
Report date
28 May 2021
Price
$2.28
Ownership
Direct
Form 4 holding EVP & Chief Financial Officer

INTERCEPT PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
08 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Andrew Saik

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .